← FDA Drug Approvals (Drugs@FDA)
MONTELUKAST SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2016-10-28
Drug application
- FDA Application #
ANDA207463- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MONTELUKAST SODIUM
- Generic name
- Montelukast Sodium
- Active ingredients
- MONTELUKAST SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CIPLA
- First approval
- 2016-10-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown